Ibsa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IBSA, and when can generic versions of IBSA drugs launch?
IBSA has five approved drugs.
There are seven US patents protecting IBSA drugs.
There are thirty-two patent family members on IBSA drugs in sixteen countries and one supplementary protection certificate in one country.
Summary for Ibsa
| International Patents: | 32 |
| US Patents: | 7 |
| Tradenames: | 5 |
| Ingredients: | 3 |
| NDAs: | 5 |
Drugs and US Patents for Ibsa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-006 | Oct 13, 2006 | RX | Yes | No | 7,691,411 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-004 | Dec 15, 2016 | RX | Yes | No | 11,241,382 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-008 | Dec 15, 2016 | RX | Yes | No | 11,241,382 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-003 | Dec 15, 2016 | RX | Yes | No | 11,096,913 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-003 | Dec 15, 2016 | RX | Yes | No | 11,241,382 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ibsa | LIDOCAINE | lidocaine | PATCH;TOPICAL | 209190-001 | Apr 30, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ibsa | TIROSINT-SOL | levothyroxine sodium | SOLUTION;ORAL | 206977-005 | Dec 15, 2016 | RX | Yes | No | 11,096,913 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ibsa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-010 | Oct 2, 2009 | 7,691,411 | ⤷ Sign Up |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-005 | Oct 13, 2006 | 7,691,411 | ⤷ Sign Up |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-009 | Oct 2, 2009 | 7,723,390 | ⤷ Sign Up |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-011 | Apr 25, 2017 | 7,723,390 | ⤷ Sign Up |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-009 | Oct 2, 2009 | 7,691,411 | ⤷ Sign Up |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-013 | Aug 1, 2007 | 7,691,411 | ⤷ Sign Up |
| Ibsa | TIROSINT | levothyroxine sodium | CAPSULE;ORAL | 021924-007 | Oct 13, 2006 | 7,691,411 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for IBSA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Patch | 1.3% | ➤ Subscribe | 2015-06-26 |
International Patents for Ibsa Drugs
Supplementary Protection Certificates for Ibsa Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1291021 | 132012902104794 | Italy | ⤷ Sign Up | PRODUCT NAME: LEVOTIROXINA SODICA(ALIASINT); AUTHORISATION NUMBER(S) AND DATE(S): RVG 106848; 106850-106860, 20110407;DA 041528011/M A 041528365/M, 20120808 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
